Use of Pamidronate for Hypercalcemia of Malignancy in Renal Dysfunction.
Sarah J NormanDavid J ReevesLindsay M SaumPublished in: Journal of pharmacy practice (2019)
Pamidronate appears to have limited impact on renal function at doses up to 90 mg in the setting of pre-existing renal dysfunction for the treatment of HCM.